About Egalet
Egalet is a company based in Værløse (Denmark) founded in 1995. Egalet has raised $70.88 million across 8 funding rounds from investors including Danske Bank, Atlas Venture and Index Ventures. The company has 1 employees as of January 31, 2020. Egalet has completed 1 acquisition, including SPRIX. Egalet offers products and services including Pharmaceutical Products. Egalet operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter Værløse, Denmark
- Employees 1 as on 31 Jan, 2020
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Assertio Holdings, Inc.
-
Annual Revenue
$2.01 M (USD)-78as on Dec 31, 2024
-
Net Profit
-$21.58 M (USD)93as on Dec 31, 2024
-
EBITDA
-$24.48 M (USD)90as on Dec 31, 2024
-
Total Equity Funding
$70.88 M (USD)
in 8 rounds
-
Latest Funding Round
$42.16 M (USD), Post-IPO
Feb 19, 2019
-
Investors
Danske Bank
& 8 more
-
Employee Count
1
as on Jan 31, 2020
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Egalet
Egalet offers a comprehensive portfolio of products and services, including Pharmaceutical Products.
Develops and distributes prescription drugs for medical treatments
People of Egalet
Unlock access to complete
Funding Insights of Egalet
Egalet has successfully raised a total of $70.88M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $42.16 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Egalet
Egalet has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Danske Bank, Atlas Venture and Index Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology startups and entrepreneurs.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in life science and biotechnology sectors
|
Locked | Locked | Locked | |
|
Investments are made by Sunstone in early-stage European companies.
|
Locked | Locked | Locked |
Investor details for Egalet
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Egalet
Egalet has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SPRIX.
Investment portfolio details for Egalet
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pain relief nasal spray product is featured on SPRIX website.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for Egalet
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Egalet
Detailed financials for Egalet
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Egalet Comparisons
Peer comparison for Egalet
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Egalet
Egalet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| Locked | Locked | Locked |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| Locked | Locked | Locked |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| Locked | Locked | Locked |
Therapies for pain and addiction treatment are developed.
|
|
| Locked | Locked | Locked |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| Locked | Locked | Locked |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
Detailed competitors of Egalet
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Egalet
Complete news archive for Egalet
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Egalet
Egalet was founded in 1995 and raised its 1st funding round 11 years after it was founded.
Egalet is headquartered in Værløse, Denmark.
Egalet is a funded company, having raised a total of $70.88M across 8 funding rounds to date.
As of Jan 31, 2020, the latest employee count at Egalet is 1.
Annual revenue of Egalet is $2.01M as on Dec 31, 2024.
Founded in 1995 and based in Vaerlose, Denmark, the company operates in the pharmaceutical sector. Focus is placed on developing therapeutics for pain management, including a pipeline of clinical-stage opioid-based product candidates. These candidates are engineered to resist abuse through physical and chemical manipulation. The underlying technology is applied across various pharmaceutical classes and supports combination products featuring multiple active ingredients with varied release profiles.
Egalet's top competitors include Flexion Therapeutics, Cara Therapeutics and Trevena.
Egalet offers Pharmaceutical Products.
Egalet has made 1 acquisition, including SPRIX.
Egalet has 9 investors. Key investors include Danske Bank, Atlas Venture, Index Ventures, Sunstone, and Omega Funds.